• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组学全球化中的纳入与排除;以巴西的罕见遗传病为例。

Inclusion and exclusion in the globalisation of genomics; the case of rare genetic disease in Brazil.

作者信息

Gibbon Sahra, Aureliano Waleska

机构信息

a Department of Anthropology , University College London , London , UK.

b Department of Anthropology , Universidade do Estado do Rio de Janeiro , Rio de Janeiro , Brazil.

出版信息

Anthropol Med. 2018 Apr;25(1):11-29. doi: 10.1080/13648470.2017.1381230.

DOI:10.1080/13648470.2017.1381230
PMID:29533091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5890301/
Abstract

Within the context of a globalising agenda for genetic research where 'global health' is increasingly seen as necessarily informed by and having to account for genomics, the focus on rare genetic diseases is becoming prominent. Drawing from ethnographic research carried out separately by both authors in Brazil, this paper examines how an emerging focus on two different arenas of rare genetic disease, cancer genetics and a class of degenerative neurological diseases known as Ataxias, is subject to and a product of the dynamics of inclusion and exclusion as this concerns participation in research and access to health care. It examines how in these different cases 'rarenesss' has been diversely situated and differently politicised and how clinicians, patients and their families grapple with the slippery boundaries between research, rights to health and the limits of care, therapy or prevention. It illustrates how attention to rare genetic disease in Brazil emerges at the intersection of a particular history of genetic research and public health infrastructure, densely complicated feedback loops between clinical care and research, patient mobilisation around the 'judicialisation' of health and recent state legislation regarding rare disease in Brazil. It highlights the relevance of local configurations in the way rare genetic disease is being made relevant for and by different communities.

摘要

在“全球健康”越来越被视为必然受到基因组学影响并必须考虑基因组学的全球化基因研究议程背景下,对罕见遗传病的关注正日益凸显。本文借鉴两位作者分别在巴西开展的人种志研究,探讨了对罕见遗传病两个不同领域(癌症遗传学和一类称为共济失调的退行性神经疾病)的新关注,是如何受制于以及成为包容与排斥动态变化的产物,这种动态变化涉及研究参与和医疗保健获取。它考察了在这些不同案例中,“罕见性”是如何以不同方式定位和政治化的,以及临床医生、患者及其家属如何应对研究、健康权与护理、治疗或预防限度之间模糊的界限。它说明了巴西对罕见遗传病的关注是如何出现在基因研究特定历史与公共卫生基础设施的交叉点上,临床护理与研究之间密集复杂的反馈循环,围绕健康“司法化”的患者动员以及巴西近期关于罕见病的国家立法之中。它强调了地方格局在使罕见遗传病与不同社区相关并由不同社区塑造方面的相关性。

相似文献

1
Inclusion and exclusion in the globalisation of genomics; the case of rare genetic disease in Brazil.基因组学全球化中的纳入与排除;以巴西的罕见遗传病为例。
Anthropol Med. 2018 Apr;25(1):11-29. doi: 10.1080/13648470.2017.1381230.
2
Entangled local biologies: genetic risk, bodies and inequities in Brazilian cancer genetics.纠缠的本土生物学:巴西癌症遗传学中的遗传风险、身体与不平等
Anthropol Med. 2017 Aug;24(2):174-188. doi: 10.1080/13648470.2017.1326756. Epub 2017 Jul 19.
3
[Family Therapeutic Trajectories: rare hereditary diseases involving long-term suffering].[家庭治疗轨迹:涉及长期痛苦的罕见遗传性疾病]
Cien Saude Colet. 2018 Feb;23(2):369-380. doi: 10.1590/1413-81232018232.21832017.
4
From the search for diagnosis to treatment uncertainties: challenges of care for rare genetic diseases in Brazil.从诊断探索到治疗不确定性:巴西罕见遗传病护理面临的挑战
Cien Saude Colet. 2019 Sep 26;24(10):3637-3650. doi: 10.1590/1413-812320182410.01612019. eCollection 2019.
5
Genomics of rare genetic diseases-experiences from India.罕见遗传病的基因组学:来自印度的经验。
Hum Genomics. 2019 Sep 25;14(1):52. doi: 10.1186/s40246-019-0215-5.
6
2016 Curt Stern Award Address: From Rare to Common Diseases: Translating Genetic Discovery to Therapy.2016年柯特·斯特恩奖演讲:从罕见病到常见疾病——将基因发现转化为治疗方法
Am J Hum Genet. 2017 Mar 2;100(3):397-400. doi: 10.1016/j.ajhg.2017.02.001.
7
New problems of a new health system: the creation of a national public policy of rare diseases care in Brazil (1990s-2010s).新卫生体制下的新问题:巴西罕见病护理国家公共政策的制定(20 世纪 90 年代至 21 世纪 10 年代)。
Salud Colect. 2020 Apr 5;16:e2210. doi: 10.18294/sc.2020.2210.
8
The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience.患者组织在塑造罕见遗传疾病研究、卫生政策和卫生服务方面的作用:荷兰经验。
Genes (Basel). 2024 Sep 3;15(9):1162. doi: 10.3390/genes15091162.
9
Fighting rare diseases: the model of the telethon research institutes in Italy.对抗罕见病:意大利电视募捐研究机构的模式
Hum Gene Ther. 2015 Apr;26(4):183-5. doi: 10.1089/hum.2015.2501.
10
Translating Population Difference: The Use and Re-Use of Genetic Ancestry in Brazilian Cancer Genetics.解读人群差异:巴西癌症遗传学中遗传血统的应用与再利用
Med Anthropol. 2016;35(1):58-72. doi: 10.1080/01459740.2015.1091818. Epub 2015 Oct 9.

引用本文的文献

1
Legitimate suffering: a case of belonging and sickle cell trait in Brazil.合法的苦难:巴西一个关于归属感与镰状细胞性状的案例。
Biosocieties. 2021;16(4):492-513. doi: 10.1057/s41292-021-00250-8. Epub 2021 Oct 27.

本文引用的文献

1
Translating Population Difference: The Use and Re-Use of Genetic Ancestry in Brazilian Cancer Genetics.解读人群差异:巴西癌症遗传学中遗传血统的应用与再利用
Med Anthropol. 2016;35(1):58-72. doi: 10.1080/01459740.2015.1091818. Epub 2015 Oct 9.
2
Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.发展中国家对基因组研究的理解:对马里疟疾基因组计划参与者观点的定性研究
BMC Med Ethics. 2015 Jun 16;16:42. doi: 10.1186/s12910-015-0035-7.
3
Genetics in primary health care and the National Policy on Comprehensive Care for People with Rare Diseases in Brazil: opportunities and challenges for professional education.巴西初级卫生保健中的遗传学与国家罕见病患者综合护理政策:专业教育的机遇与挑战
J Community Genet. 2015 Jul;6(3):231-40. doi: 10.1007/s12687-015-0224-6. Epub 2015 Apr 18.
4
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.安吉丽娜·朱莉效应:名人的高知名度如何对癌症相关服务的提供产生重大影响。
Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
5
Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.巴西乳腺癌患者中TP53基因p.R337H突变的患病率。
PLoS One. 2014 Jun 17;9(6):e99893. doi: 10.1371/journal.pone.0099893. eCollection 2014.
6
Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal.遗传性脑腱型肌营养不良症(Machado-Joseph Disease)的遗传咨询和症状前检测计划:来自巴西和葡萄牙的经验教训。
Genet Mol Biol. 2014 Mar;37(1 Suppl):263-70. doi: 10.1590/s1415-47572014000200012.
7
A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.碳酸锂治疗马查多-约瑟夫病的随机2期临床试验。
Mov Disord. 2014 Apr;29(4):568-73. doi: 10.1002/mds.25803. Epub 2014 Jan 7.
8
[Could endogamy explain the higher prevalence of disabilities in the population of the Brazilian Northeast?].[族内通婚能否解释巴西东北部人口中残疾率较高的现象?]
Cien Saude Colet. 2013 Apr;18(4):1141-50. doi: 10.1590/s1413-81232013000400027.
9
Genetic services and testing in Brazil.巴西的基因服务与检测。
J Community Genet. 2013 Jul;4(3):355-75. doi: 10.1007/s12687-012-0096-y. Epub 2012 May 5.
10
[Consequences of the judicialization of health policies: the cost of medicines for mucopolysaccharidosis].[卫生政策司法化的后果:黏多糖贮积症药物的成本]
Cad Saude Publica. 2012 Mar;28(3):479-89. doi: 10.1590/s0102-311x2012000300008.